News & Blog
Latest from the Blog
-
July 8, 2013 National Brain Tumor Society Names New Board Chair
National Brain Tumor Society announced the appointment of Michael J. Nathanson as Chair of its Board of Directors on July 8, 2013.
Read more | -
June 25, 2013 Jumpstarting Brain Tumor Drug Development
National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.
Read more | -
June 17, 2013 National Brain Tumor Society’s First Community Research Fund
National Brain Tumor Society and OligoNation announced Dr. David Louis, MD, of Massachusetts General Hospital and Harvard Medical School, and Dr. Anders Persson, PhD, of The University of California, San Francisco as the first grant recipients of the Oligodendroglioma Research Fund.
Read more |